These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22962579)

  • 1. Poly I:C enhances susceptibility to secondary pulmonary infections by gram-positive bacteria.
    Tian X; Xu F; Lung WY; Meyerson C; Ghaffari AA; Cheng G; Deng JC
    PLoS One; 2012; 7(9):e41879. PubMed ID: 22962579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice.
    Lee B; Robinson KM; McHugh KJ; Scheller EV; Mandalapu S; Chen C; Di YP; Clay ME; Enelow RI; Dubin PJ; Alcorn JF
    Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(2):L158-67. PubMed ID: 26001778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection.
    Shepardson KM; Larson K; Morton RV; Prigge JR; Schmidt EE; Huber VC; Rynda-Apple A
    mBio; 2016 May; 7(3):. PubMed ID: 27143388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.
    Parker D
    J Infect Dis; 2017 Feb; 215(suppl_1):S58-S63. PubMed ID: 28375519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I Interferon Signaling Is a Common Factor Driving Streptococcus pneumoniae and Influenza A Virus Shedding and Transmission.
    Zangari T; Ortigoza MB; Lokken-Toyli KL; Weiser JN
    mBio; 2021 Feb; 12(1):. PubMed ID: 33593970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice.
    Kudva A; Scheller EV; Robinson KM; Crowe CR; Choi SM; Slight SR; Khader SA; Dubin PJ; Enelow RI; Kolls JK; Alcorn JF
    J Immunol; 2011 Feb; 186(3):1666-1674. PubMed ID: 21178015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing roles of Toll-like receptor and cytosolic DNA-STING signaling pathways for Staphylococcus aureus cutaneous host defense.
    Scumpia PO; Botten GA; Norman JS; Kelly-Scumpia KM; Spreafico R; Ruccia AR; Purbey PK; Thomas BJ; Modlin RL; Smale ST
    PLoS Pathog; 2017 Jul; 13(7):e1006496. PubMed ID: 28704551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular RNA recognition pathway activates strong anti-viral response in human mast cells.
    Lappalainen J; Rintahaka J; Kovanen PT; Matikainen S; Eklund KK
    Clin Exp Immunol; 2013 Apr; 172(1):121-8. PubMed ID: 23480192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Interleukin-12 in Protection against Pulmonary Infection with Methicillin-Resistant Staphylococcus aureus.
    Nguyen QT; Furuya Y; Roberts S; Metzger DW
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6308-16. PubMed ID: 26248370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cGAS/STING Pathway Detects Streptococcus pneumoniae but Appears Dispensable for Antipneumococcal Defense in Mice and Humans.
    Ruiz-Moreno JS; Hamann L; Jin L; Sander LE; Puzianowska-Kuznicka M; Cambier J; Witzenrath M; Schumann RR; Suttorp N; Opitz B
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263110
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.
    Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD
    J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Reddinger RM; Luke-Marshall NR; Sauberan SL; Hakansson AP; Campagnari AA
    mBio; 2018 Jan; 9(1):. PubMed ID: 29317512
    [No Abstract]   [Full Text] [Related]  

  • 13. Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract.
    Parker D; Martin FJ; Soong G; Harfenist BS; Aguilar JL; Ratner AJ; Fitzgerald KA; Schindler C; Prince A
    mBio; 2011; 2(3):e00016-11. PubMed ID: 21586648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of toll-like receptor signaling pathway for protection against influenza virus infection.
    Wong JP; Christopher ME; Viswanathan S; Karpoff N; Dai X; Das D; Sun LQ; Wang M; Salazar AM
    Vaccine; 2009 May; 27(25-26):3481-3. PubMed ID: 19200852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 IFN mediates cross-talk between innate and adaptive immunity that abrogates transplantation tolerance.
    Thornley TB; Phillips NE; Beaudette-Zlatanova BC; Markees TG; Bahl K; Brehm MA; Shultz LD; Kurt-Jones EA; Mordes JP; Welsh RM; Rossini AA; Greiner DL
    J Immunol; 2007 Nov; 179(10):6620-9. PubMed ID: 17982052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes.
    Li K; Chen Z; Kato N; Gale M; Lemon SM
    J Biol Chem; 2005 Apr; 280(17):16739-47. PubMed ID: 15737993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIG-like helicase innate immunity inhibits vascular endothelial growth factor tissue responses via a type I IFN-dependent mechanism.
    Ma B; Dela Cruz CS; Hartl D; Kang MJ; Takyar S; Homer RJ; Lee CG; Elias JA
    Am J Respir Crit Care Med; 2011 May; 183(10):1322-35. PubMed ID: 21278304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs.
    Yarilina A; DiCarlo E; Ivashkiv LB
    J Immunol; 2007 Feb; 178(4):2204-11. PubMed ID: 17277125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of Toll-like Receptor 3-induced type I interferon in murine coronavirus infection of macrophages.
    Mazaleuskaya L; Veltrop R; Ikpeze N; Martin-Garcia J; Navas-Martin S
    Viruses; 2012 May; 4(5):901-23. PubMed ID: 22754655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza "Trains" the Host for Enhanced Susceptibility to Secondary Bacterial Infection.
    Shirey KA; Perkins DJ; Lai W; Zhang W; Fernando LR; Gusovsky F; Blanco JCG; Vogel SN
    mBio; 2019 May; 10(3):. PubMed ID: 31064834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.